NILE THERAPEUTICS Aktie

0,14 EUR -0,7092%

Zu Ihrem Onlinebroker

kaufen verkaufen

NILE THERAPEUTICS Aktienkurs : 25.05. ( 15 Min. verzögert)
0,140 € Letzter Kurs	-0,71% Veränderung	0,141 € Vortag	0,140 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,140 - 0,140 Tag	0,584 - 0,138 52 Wochen	0 Tag	29 Ø 52 Wochen	0,161 74.600 Stücke	0,201 59.800 Stücke

NILE THERAPEUTICS Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

16.05.

Nile Digs In

By Jason Napodano, CFA On May 15, 2012, Nile Therapeutics (NLTX - Analyst Report) reported financial results for the first quarter 2012. The company reported grant revenues of $195K in...
15.05.

Nile Therapeutics Reports 2012 First Quarter Financial Results

SAN FRANCISCO, May 15, 2012 /PRNewswire via COMTEX/ -- Nile Therapeutics, Inc. (otcqb:NLTX), a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced its first quarter financial results...

11.05.

Myrexis Appoints New Executive Management Team in Alignment With Strategic ...

Mr. Brewer has been the Executive Chairman of Nile Therapeutics, Inc., a biopharmaceutical company, since July 2010. Mr. Brewer is a director of SRI International, an independent, non-profit research group,...
11.05.

Myrexis Appoints New Executive Management Team in Alignment With Strategic ...

Mr. Brewer has been the Executive Chairman of Nile Therapeutics, Inc., a biopharmaceutical company, since July 2010. Mr. Brewer is a director of SRI International, an independent, non-profit research group,...